AVO-1681

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAVO-1681
Drug Alias NameAVO-1681
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCholangitis, Sclerosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesAvolynt
China Registration ClassN/A

Develop Information

Active CompaniesAvolynt
Inactive CompaniesN/A
Active IndicationsCholangitis, Sclerosing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A